Delivery Order SPE2DR25D6028-SPE2DR26FASLV
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,249.33 delivery order on December 2, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,894.88 for Methylphenidate ER(LA) 20mg tablets (100 count) on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) with a firm fixed price of $1,301.40. This non-set-aside contract was competitively awarded and is scheduled for completion by November 25, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of methylphenidate ER 18mg tablets (100 count) under a firm fixed-price contract valued at $4,919.16. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The contract is set to be completed...
- The Defense Logistics Agency awarded a $1,346.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 27 mg on November 24, 2025, with completion scheduled for November 25, 2025. This order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.28 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,716.72 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count units). This competitive, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of December 1, 2025. The award was issued on November 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.19 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The product will be delivered to the company's facility...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.67 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count containers) with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASLVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,123.01 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27mg (100 tablets) on December 8, 2025, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's broad portfolio of federal contracts encompasses a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains. This delivery order for methylphenidate, a controlled substance commonly used for attention-deficit/hyperactivity disorder treatment, exemplifies the routine pharmaceutical supply chain support the contractor provides to Defense Health Agency customers and other government healthcare entities through its extensive contract vehicle with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/7/25 |